Treatment of hepatitis B and C after liver transplantation. Part 2, hepatitis C.
about
The prevention of infection post-transplant: the role of prophylaxis, preemptive and empiric therapy.Outcome after liver re-transplantation in patients with recurrent chronic hepatitis C.Pegylated interferon alpha-2b for patients with HCV recurrence and graft fibrosis following liver transplantation.Pure red cell aplasia associated with concomitant use of mycophenolate mofetil and ribavirin in post-transplant recurrent hepatitis C.The use of partial splenic artery embolization made it possible to administer interferon and ribavirin therapy in a liver transplant patient with fibrosing cholestatic hepatitis C complicated with thrombocytopenia.
P2860
Treatment of hepatitis B and C after liver transplantation. Part 2, hepatitis C.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Treatment of hepatitis B and C after liver transplantation. Part 2, hepatitis C.
@ast
Treatment of hepatitis B and C after liver transplantation. Part 2, hepatitis C.
@en
type
label
Treatment of hepatitis B and C after liver transplantation. Part 2, hepatitis C.
@ast
Treatment of hepatitis B and C after liver transplantation. Part 2, hepatitis C.
@en
prefLabel
Treatment of hepatitis B and C after liver transplantation. Part 2, hepatitis C.
@ast
Treatment of hepatitis B and C after liver transplantation. Part 2, hepatitis C.
@en
P2860
P1476
Treatment of hepatitis B and C after liver transplantation. Part 2, hepatitis C.
@en
P2093
Bruno Roche
Didier Samuel
P2860
P304
P356
10.1111/J.1432-2277.2004.TB00508.X
P577
2005-02-02T00:00:00Z